Return to homepagePandemic Pact

Contribution to NordForsk's call for Nordic health data research project on COVID-19

  • Funded by The Research Council of Norway (RCN)
  • Total publications:20 publications

Grant number: 322942

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Known Financial Commitments (USD)

    $598,617.57

  • Funder

    The Research Council of Norway (RCN)

  • Principal Investigator

    Mikael Heimonen

  • Research Location

    Norway

  • Lead Research Institution

    NORDFORSK

  • Research Priority Alignment

    N/A

  • Research Category

    14

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

20 Publications linked via Europe PMC

Last Updated:3 days ago

View all publications at Europe PMC

Fluorescence polarisation activity-based protein profiling for the identification of deoxynojirimycin-type inhibitors selective for lysosomal retaining alpha- and beta-glucosidases.

1,6-epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease.

Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo.

Structural Insights into Pixatimod (PG545) Inhibition of Heparanase, a Key Enzyme in Cancer and Viral Infections.

Design, Synthesis and Structural Analysis of Glucocerebrosidase Imaging Agents.

An Epoxide Intermediate in Glycosidase Catalysis.

Synthetic and Crystallographic Insight into Exploiting sp2 Hybridization in the Development of α-l-Fucosidase Inhibitors.

Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish.

Structural and Biochemical Insights into the Function and Evolution of Sulfoquinovosidases.